Psychopharmacology News and Research

RSS

Psychopharmacology is the study of drug-induced changes in mood, sensation, thinking, and behavior.

Experts review advances in understanding, treatment of bipolar disorder

Several lines of research have opened exciting new frontiers in scientific understanding and clinical management of bipolar disorder. Recent advances in bipolar disease research are described in this month's special issue of Harvard Review of Psychiatry.

11 Nov 2014

Women survivors of sexual abuse may suffer emotional distress during pelvic examination

Women who have a history of violent sexual abuse may suffer emotional distress during a routine pelvic examination. Healthcare providers would benefit from greater awareness of symptoms predictive of examination-related distress in this patient population, according to a study published in Violence and Gender, a new peer-reviewed journal from Mary Ann Liebert, Inc., publishers.

3 Oct 2014

HGSAS launches new online master's degree

The Higher Learning Commission recently granted approval to launch the new online master's degree offered by the Hazelden Graduate School of Addiction Studies (HGSAS).

22 Aug 2014

Research results in new insights into clinical depression

Research led by the University of Adelaide has resulted in new insights into clinical depression that demonstrate there cannot be a "one-size-fits-all" approach to treating the disease.

4 Aug 2014

OUP, CINP partner to publish International Journal of Neuropsychopharmacology

Oxford University Press is pleased to announce its new relationship with the International College of Neuropsychopharmacology.

31 Jul 2014

Psychostimulant increases risk of cardiovascular events in children with ADHD

Psychostimulant use to treat children and adolescents with attention-deficit/hyperactivity disorder (ADHD) is increasing worldwide, and the evaluation of the cardiovascular safety of stimulant medication used in treatment has been a recent topic of concern.

28 Jun 2014

Alkermes reports data from aripiprazole lauroxil phase 3 clinical trial for treatment of schizophrenia

Alkermes plc today announced the presentation of data from its phase 3 clinical trial of aripiprazole lauroxil, an investigational drug candidate in development for schizophrenia, at the American Society of Clinical Psychopharmacology Annual Meeting in Hollywood, Fla.

18 Jun 2014

Study compares effectiveness of duloxetine and fluoxetine in children with MDD

Two studies of the anti-depressive drug duloxetine, a serotonin-norepinephrine reuptake inhibitor (SNRI), compared its effectiveness and safety to either fluoxetine or placebo in children and adolescents with major depressive disorder (MDD).

20 May 2014

Psychiatrist wins Kempf Fund Award for Research Development in Psychobiological Psychiatry

Dr. Peter F. Buckley, a psychiatrist specializing in schizophrenia and Dean of the Medical College of Georgia at Georgia Regents University, is the 2014 winner of the Kempf Fund Award for Research Development in Psychobiological Psychiatry from the American Psychiatric Association.

6 May 2014

Green tea extract enhances cognitive functions in brain

Green tea is said to have many putative positive effects on health. Now, researchers at the University of Basel are reporting first evidence that green tea extract enhances the cognitive functions, in particular the working memory.

8 Apr 2014

Ketamine offers novel treatment for patients with severe depression

New data show ketamine (a drug widely used for anaesthesia and pain relief) has a rapid antidepressant effect in some patients with severe depression. The first UK study of ketamine intravenous infusions in people with treatment-resistant depression was conducted by the Oxford Health NHS Foundation Trust and the University of Oxford.

3 Apr 2014

Researchers identify distinct profiles of brain activity present when making decisions

Although choosing to do something because the perceived benefit outweighs the financial cost is something people do daily, little is known about what happens in the brain when a person makes these kinds of decisions.

12 Mar 2014

Harvard Review of Psychiatry provides updates on ASD research

Recent years have seen exciting progress in key areas of research on autism spectrum disorders (ASD): from possible genetic causes, to effective treatments for common symptoms and clinical problems, to promoting success for young people with ASD entering college. Updates on these and other advances in ASD research are presented in the March special issue of Harvard Review of Psychiatry.

10 Mar 2014

Just one drink can affect driving abilities of older drivers

You may have only had one glass of wine with dinner, but if you're 55 or older, that single serving may hit you hard enough to make you a dangerous driver.

10 Mar 2014

FSU researchers link prenatal nicotine exposure to future ADHD

Prenatal exposure to nicotine could manifest as attention deficit hyperactivity disorder in children born a generation later, according to a new study by Florida State University College of Medicine researchers.

28 Feb 2014

Research examines differences between male and female brain that contributes to violent behavior

Human behaviors such as violence depend on interactions in the brain between genetic and environmental factors. An individual may be more vulnerable to developing violent behaviors if they have predisposing factors and are then exposed to stress, abuse, or other triggers, especially early in life.

6 Feb 2014

Susceptible loci identified for bipolar I disorder in Taiwanese

Researchers have identified three genetic loci that may be linked to bipolar I disorder risk in Taiwanese individuals.

29 Jan 2014

10 simple points to know and monitor alcohol intake

Much the same way individuals are encouraged to know their blood pressure and cholesterol numbers to maintain a healthy lifestyle, a new editorial in the Journal of Psychopharmacology urges the European public to know and monitor their alcohol intake number using a simple 10 point plan.

7 Jan 2014

Portage acquires approximately 54% equity in Biohaven

Portage Biotech Inc., is pleased to announce that it has acquired approximately 54% equity in Biohaven Pharmaceutical Holding Company Limited, a private corporation formed under the laws of the British Virgin Islands, for $3.5 million, payable as $1.75 million upfront and the balance in three installments over the next eleven months.

6 Jan 2014

"Appearance exposure" on Internet linked to body image disturbance among adolescent girls

"Appearance exposure" on the Internet has been linked to body image disturbance among adolescent girls. A new study that links specific Facebook activities, but not overall Facebook use to body dissatisfaction and a drive for thinness in teen girls is published in Cyberpsychology, Behavior, and Social Networking, a peer-reviewed journal from Mary Ann Liebert, Inc., publishers.

4 Dec 2013